A detailed history of Buckingham Strategic Partners transactions in Cerus Corp stock. As of the latest transaction made, Buckingham Strategic Partners holds 22,589 shares of CERS stock, worth $36,594. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,589
Previous 19,930 13.34%
Holding current value
$36,594
Previous $28,000 25.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$1.16 - $1.6 $3,084 - $4,254
2,659 Added 13.34%
22,589 $35,000
Q2 2025

Jul 31, 2025

BUY
$1.22 - $1.51 $9,596 - $11,877
7,866 Added 65.2%
19,930 $28,000
Q1 2025

May 15, 2025

BUY
$1.39 - $2.15 $16,768 - $25,937
12,064 New
12,064 $16,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $287M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Buckingham Strategic Partners Portfolio

Follow Buckingham Strategic Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckingham Strategic Partners, based on Form 13F filings with the SEC.

News

Stay updated on Buckingham Strategic Partners with notifications on news.